5-methylpyrazole-3-carboxylic acid has been researched along with isatin in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 3 (100.00) | 2.80 |
Authors | Studies |
---|---|
Abell, C; Acebrón-García-de-Eulate, M; Blundell, TL; Brown, KP; Coyne, AG; Di Pietro, O; Floto, RA; Hess, J; Holland, MTO; Kim, SY; Marchetti, C; Mayol-Llinàs, J; Mendes, V | 1 |
Hitge, R; Petzer, A; Petzer, JP | 2 |
3 other study(ies) available for 5-methylpyrazole-3-carboxylic acid and isatin
Article | Year |
---|---|
Discovery of Novel Inhibitors of Uridine Diphosphate-
Topics: Anti-Bacterial Agents; Bacterial Proteins; Binding Sites; Catalytic Domain; Crystallography, X-Ray; Cystic Fibrosis; Drug Evaluation, Preclinical; Humans; Ligands; Molecular Conformation; Molecular Docking Simulation; Oxidoreductases; Pseudomonas aeruginosa; Pseudomonas Infections; Pyrazoles | 2022 |
Isatoic anhydrides as novel inhibitors of monoamine oxidase.
Topics: Acetylcholinesterase; Amines; Amino Acids; Anhydrides; Butyrylcholinesterase; Cholinesterase Inhibitors; Humans; Molecular Docking Simulation; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Phthalimides; Protein Isoforms; Quinolones; Structure-Activity Relationship | 2022 |
The inhibition of monoamine oxidase by 2H-1,4-benzothiazin-3(4H)-ones.
Topics: Humans; Molecular Docking Simulation; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Parkinson Disease; Structure-Activity Relationship | 2022 |